Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The daily Top 10 COVID papers

  Ovarian Neoplasms

  Free Subscription


1 Am J Surg
1 Ann Oncol
1 Cancer Lett
1 Clin Cancer Res
1 Eur J Obstet Gynecol Reprod Biol
3 Gynecol Oncol
2 Int J Gynaecol Obstet
1 J Clin Oncol
1 Lancet Oncol
2 Oncogene
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Surg

  1. PETERSEN S, Shahiri P, Jewell A, Spoozak L, et al
    Disparities in ovarian cancer survival at the only NCI-designated cancer center in Kansas.
    Am J Surg. 2020 Dec 7. pii: S0002-9610(20)30787.
    PubMed         Abstract available

    Ann Oncol

  2. PILIE PG, George A, Yap TA
    Patient selection biomarker strategies for PARP inhibitor therapy.
    Ann Oncol. 2020;31:1603-1605.

    Cancer Lett

  3. ZHANG M, Wang Y, Matyunina LV, Akbar A, et al
    The ability of miRNAs to induce mesenchymal-to-epithelial transition (MET) in cancer cells is highly dependent upon genetic background.
    Cancer Lett. 2020;480:15-23.
    PubMed         Abstract available

    Clin Cancer Res

  4. PARACCHINI L, Beltrame L, Grassi T, Inglesi A, et al
    Genome-wide copy number alterations in circulating tumor DNA as a novel biomarker in high grade serous ovarian cancer patients.
    Clin Cancer Res. 2020 Dec 15. pii: 1078-0432.CCR-20-3345.
    PubMed         Abstract available

    Eur J Obstet Gynecol Reprod Biol

  5. TARANNUM A, Sheikh H, Appiah-Sakyi K, Lindow SW, et al
    The diagnostic use of magnetic resonance imaging for acute abdominal and pelvic pain in pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2019 Nov 22. pii: S0301-2115(19)30542.
    PubMed         Abstract available

    Gynecol Oncol

  6. YUE H, Li W, Chen R, Wang J, et al
    Stromal POSTN induced by TGF-beta1 facilitates the migration and invasion of ovarian cancer.
    Gynecol Oncol. 2020 Dec 11. pii: S0090-8258(20)34154.
    PubMed         Abstract available

  7. KARNEZIS AN, Chen SY, Chow C, Yang W, et al
    Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines.
    Gynecol Oncol. 2020 Dec 13. pii: S0090-8258(20)34175.
    PubMed         Abstract available

  8. FREY MK, Chapman-Davis E, Glynn SM, Lin J, et al
    Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic.
    Gynecol Oncol. 2020 Nov 19. pii: S0090-8258(20)34128.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  9. KIM SR, Kotsopoulos J, Sun P, Bernardini M, et al
    The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on ten-year survival from advanced ovarian cancer.
    Int J Gynaecol Obstet. 2020 Dec 16. doi: 10.1002/ijgo.13542.
    PubMed         Abstract available

  10. RODRIGUEZ J, Fletcher A, Heredia F, Fernandez R, et al
    Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.
    Int J Gynaecol Obstet. 2020 Jun 11. doi: 10.1002/ijgo.13272.
    PubMed         Abstract available

    J Clin Oncol

  11. YANG X, Leslie G, Doroszuk A, Schneider S, et al
    Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
    J Clin Oncol. 2020;38:674-685.
    PubMed         Abstract available

    Lancet Oncol

  12. ROSE PG, Mahdi H
    Landmark studies of therapeutic vaccination in cervical and ovarian cancers.
    Lancet Oncol. 2020;21:1549-1550.


  13. MEHNER C, Miller E, Hockla A, Coban M, et al
    Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma.
    Oncogene. 2020 Sep 14. pii: 10.1038/s41388-020-01451.
    PubMed         Abstract available

  14. RANZUGLIA V, Lorenzon I, Pellarin I, Sonego M, et al
    Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells.
    Oncogene. 2020;39:6370-6386.
    PubMed         Abstract available

    PLoS One

  15. LEANDERSSON P, Akesson A, Hedenfalk I, Malander S, et al
    A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
    PLoS One. 2020;15:e0240418.
    PubMed         Abstract available

  16. WANG Y, Tao VL, Shin CY, Salamanca C, et al
    Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.
    PLoS One. 2020;15:e0240412.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.